Epitalon (also known as Epithalon or Epithalone) is a synthetic tetrapeptide composed of Ala-Glu-Asp-Gly. Designed as a synthetic mimic of Epithalamin (a natural peptide produced by the pineal gland), it is widely recognized in anti-aging and bio-gerontological research for its unique ability to activate telomerase, elongate telomeres, and regulate neuroendocrine systems.
What Studies Show (Layman Summary):
Epitalon acts at the chromosomal level to address cellular aging and systemic decline. Extensive long-term clinical and preclinical research highlights its potential for:
Telomere Elongation & Cellular Longevity: Triggers the expression of telomerase to rebuild repetitive DNA end-caps, extending cellular lifespan and capacity for division.
Antioxidant & Immune Optimization: Enhances endogenous antioxidant enzyme activity (SOD, Glutathione) to neutralize free radicals and reduce age-related oxidative stress.
Endocrine & Metabolic Balance: Helps reset hypothalamic sensitivity and maintain balanced hormone levels into advanced age.
How It Works (Research Mechanism)
Epitalon influences fundamental cellular and genetic machinery to counteract degenerative aging processes:
Telomerase Activation: Directly induces the enzymatic activity of telomerase reverse transcriptase (TERT), allowing cells to overcome the Hayflick limit and restore eroded telomeres.
Epigenetic Gene Expression: Interacts directly with DNA promoter regions (histones and chromatin) to reactivate silenced genes associated with repair and immunity.
Oxidative Defense Enhancement: Increases expression of superoxide dismutase (SOD) and catalase, shielding DNA and cellular membranes from oxidative damage.
Research Dosing & Usage Parameters
In scientific studies and longevity protocols, Epitalon is traditionally evaluated in short, intensive cycles repeated 1 to 2 times per year rather than continuous daily administration.
Standard research parameters evaluate two common protocol models:
High-Dose Short Protocol: 5.0 mg to 10.0 mg per day administered daily for 10 to 20 consecutive days.
Micro-Dose Extended Protocol: 1.0 mg to 2.0 mg per day administered daily for 10 to 20 consecutive days.
Reconstitution & Concentration Calculation
Adding 2.0 mL of bacteriostatic water or sterile laboratory diluent creates a stock solution concentration of 5.0 mg/mL (500 mcg per 0.1 mL).
Volumetric Ratio Breakdown (with 2.0 mL reconstituted):
0.20 mL (20 units on an insulin syringe) = 1.0 mg of active Epitalon.
0.40 mL (40 units) = 2.0 mg of active Epitalon.
1.00 mL (100 units / full syringe) = 5.0 mg of active Epitalon.
2.00 mL (2 full syringes) = 10.0 mg (entire vial) of active Epitalon.
Storage & Handling Specifications
Store unopened lyophilized vials in a cool, dark environment shielded from direct light exposure. Following reconstitution with bacteriostatic water, maintain stock solutions refrigerated between 2°C – 8°C (36°F – 46°F). Reconstituted stock solutions should be utilized within 30 days to avoid degradation and maintain peak biological activity.
